Nabeel Bardeesy

Active 1992–2025

166
Papers
50,638
Citations
113
h-index
164
i10-index

Citations

Citations per year for Nabeel Bardeesy1966: 1 citations1982: 1 citations1984: 1 citations1988: 1 citations1989: 1 citations1990: 1 citations1993: 6 citations1994: 10 citations1995: 8 citations1996: 26 citations1997: 23 citations1998: 28 citations1999: 25 citations2000: 42 citations2001: 53 citations2002: 104 citations2003: 116 citations2004: 145 citations2005: 235 citations2006: 283 citations2007: 276 citations2008: 320 citations2009: 435 citations2010: 469 citations2011: 542 citations2012: 617 citations2013: 654 citations2014: 789 citations2015: 807 citations2016: 817 citations2017: 901 citations2018: 879 citations2019: 2,318 citations2020: 2,467 citations2021: 2,431 citations2022: 1,823 citations2023: 1,327 citations2024: 2,008 citations2025: 935 citations2026: 35 citations1967–1981: no citations, so these years are not shown1983: no citations, so this year is not shown1985–1987: no citations, so these years are not shown1991–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,992 citing papers, 31.2% of this breakdownChina: 4,104 citing papers, 16% of this breakdownUnited Kingdom: 1,437 citing papers, 5.6% of this breakdownGermany: 1,275 citing papers, 5% of this breakdownItaly: 1,055 citing papers, 4.1% of this breakdownJapan: 917 citing papers, 3.6% of this breakdownFrance: 880 citing papers, 3.4% of this breakdownCanada: 784 citing papers, 3.1% of this breakdownSpain: 635 citing papers, 2.5% of this breakdownSouth Korea: 556 citing papers, 2.2% of this breakdownNetherlands: 484 citing papers, 1.9% of this breakdownAustralia: 460 citing papers, 1.8% of this breakdown
0%31.2%Other 19.6%

Fields

  • Biochemistry, Genetics and Molecular Biology46.7%
  • Medicine45%
  • Immunology and Microbiology3.3%
  • Engineering1.1%
  • Neuroscience0.9%
  • Materials Science0.8%
  • Other2.2%

Topics

  • Pancreatic and Hepatic Oncology Research5.6%
  • Cancer, Hypoxia, and Metabolism3.8%
  • Metabolism, Diabetes, and Cancer3.3%
  • Epigenetics and DNA Methylation3.1%
  • Cancer Cells and Metastasis2.9%
  • Cancer Genomics and Diagnostics2.5%
  • Other78.8%

Coauthors

All papers

Open in search
  1. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric S. Lander, Bradley A. Murray, Julian M. Hess, Mara Rosenberg, Louis Bergelson, Hailei Zhang, Juok Cho, Grace Tiao, Jaegil Kim, Dimitri Livitz, Ignaty Leshchiner, Brendan Reardon, Eliezer M. Van Allen, Atanas Kamburov, Rameen Beroukhim, Gordon Saksena, Steven E. Schumacher, Michael S. Noble, David I. Heiman, Nils Gehlenborg, Jaegil Kim, Michael S. Lawrence, Volkan Adsay, Gloria M. Petersen, David S. Klimstra, Nabeel Bardeesy, Mark D.M. Leiserson, Reanne Bowlby, Katayoon Kasaian, İnanç Birol, Karen Mungall, Sara Sadeghi, John N. Weinstein, Paul T. Spellman, Yuexin Liu, Laufey T. Ámundadóttir, Joel E. Tepper, Aatur D. Singhi, Rajiv Dhir, Paul Drwiega, Thomas C. Smyrk, Lizhi Zhang, Paula Kim, Jay Bowen, Jessica Frick, Julie M. Gastier‐Foster, Mark Gerken, Kevin Lau, Kristen Leraas, Tara M. Lichtenberg, Nilsa C. Ramirez, Jeremy Renkel, Mark E. Sherman, Lisa Wise, Peggy Yena, Erik Zmuda, Juliann Shih, Adrian Ally, Miruna Balasundaram, Rebecca Carlsen, Andy Chu, Eric Chuah, Amanda Clarke, Noreen Dhalla, Robert A. Holt, Steven J.M. Jones, Darlene Lee, Yussanne Ma, Marco A. Marra, Michael Mayo and 171 more - Cancer Cell 2017 cited by 2,069

  2. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

    Authors: , , , , , , , , , , , , , , , , , - Nature 2013 cited by 2,007

  3. Pancreatic Adenocarcinoma

    Authors: , , - New England Journal of Medicine 2014 cited by 2,342

  4. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 917

  5. Pancreatic cancers require autophagy for tumor growth

    Authors: , , , , , , , , , , , , , , , , - Genes & Development 2011 cited by 1,472

  6. Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism

    Authors: , , , , , , , , , , , , , , , , - Nature 2015 cited by 807

  7. Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , - Hepatology 2019 cited by 410

  8. The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

    Authors: , , , , , , , - Science 2005 cited by 1,948

  9. Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nabeel Bardeesy, Andrew X. Zhu - Cancer Discovery 2016 cited by 545

  10. NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2023 cited by 144

  11. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bo R. Rueda, Roy J. Soberman, Nabeel Bardeesy, Brian B. Liau, Michael S. Lawrence, Matt P. Stokes, Sean A. Beausoleil, Liron Bar‐Peled - Cell 2023 cited by 147

  12. Immunology and immunotherapy of cholangiocarcinoma

    Authors: , , , , , , - Nature Reviews Gastroenterology & Hepatology 2023 cited by 181

  13. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 1,774

  14. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robin Kate Kelley, Alberto Bardelli, A. John Iafrate, William C. Hahn, Cyril H. Benes, David T. Ting, Hiroshi Hirai, Gad Getz, Dejan Juric, Andrew X. Zhu, Ryan B. Corcoran, Nabeel Bardeesy - Cancer Discovery 2019 cited by 371

  15. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth L. Appelbaum, Arshi Arora, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Nabeel Bardeesy, Oliver F. Bathe, Stephen B. Baylin, Rameen Beroukhim, Mario Berríos, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Mitesh J. Borad, Jay Bowen, Reanne Bowlby, Maria Consiglia Bragazzi, Denise Brooks, Vincenzo Cardinale, Rebecca Carlsen, Guido Carpino, André Lopes Carvalho, Roongruedee Chaiteerakij, Vishal C. Chandan, Andrew D. Cherniack, Lynda Chin, Juok Cho, Gina Choe, Eric Chuah, Sudha Chudamani, Carrie Cibulskis, Matthew G. Cordes, Kyle R. Covington, Daniel Crain, Erin Curley, Agostino Maria De Rose, Timothy Defreitas, John A. Demchok, Vikram Deshpande, Noreen Dhalla, Li Ding, Kimberley Evason, Farshad Farshidfar, Ina Felau, Martin L. Ferguson, Wai Chin Foo, Antonio Franchitto, Scott Frazer, Catrina C. Fronick, Lucinda A. Fulton, Robert S. Fulton, Stacey Gabriel, Johanna Gardner, Julie M. Gastier‐Foster, Eugenio Gaudio, Nils Gehlenborg, Giannicola Genovese, Mark Gerken, Gad Getz, Nasra H. Giama, Richard A. Gibbs, Marie-Claude Gingras, Felice Giuliante, Gian Luca Grazi, D. Neil Hayes, Apurva M. Hegde, David I. Heiman, Julian M. Hess, Toshinori Hinoue, Katherine A. Hoadley and 136 more - Cell Reports 2017 cited by 612

  16. CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice

    Authors: , , , , , , , , , , , , , , , - Hepatology 2014 cited by 458

  17. LKB1 modulates lung cancer differentiation and metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diego H. Castrillón, Nabeel Bardeesy, Norman E. Sharpless, Kwok‐Kin Wong - Nature 2007 cited by 1,079

  18. Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

    Authors: , , , , , , , , , , - Cancer Cell 2009 cited by 936

  19. A gene expression signature associated with ‘‘K-Ras addiction’’ reveals regulators of EMT and tumor cell survival

    Authors: , , , , , , - Cancer Cell 2009 cited by 864

  20. TGF-β Tumor Suppression through a Lethal EMT

    Authors: , , , , , , , - Cell 2016 cited by 611

  21. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 cited by 139

  22. Genetics and biology of pancreatic ductal adenocarcinoma

    Authors: , , , , - Genes & Development 2006 cited by 1,576

  23. Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner

    Authors: , , , , , , , , , , , , - Cell Metabolism 2010 cited by 874

  24. Mutant IDH Inhibits IFNγ–TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongwu Zheng, Robert T. Manguso, Nabeel Bardeesy - Cancer Discovery 2021 cited by 147